ZAVZPRET (NDA216386)- (EQ 10MG BASE/SPRAY)

Generic Name	ZAVEGEPANT HYDROCHLORIDE	Innovator	PFIZER
Dosage	EQ 10MG BASE/SPRAY
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2031-Oct-07	NCE Excl Expiry	2028-Mar-09
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	ZAVZPRET is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 10MG BASE/SPRAY	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of ZAVZPRET